Key result
Greater post-ACS depressive symptoms linked to slower reduction in C-reactive protein at 1 month.
Why the study?
Previous theoretical models predict that elevated inflammation may predict later depressive symptoms, but bidirectional associations in ACS patients were unclear.
Does depressive symptom severity predict changes in C-reactive protein, or vice versa, in patients with acute coronary syndromes?
Cohort (n=163)
Does depressive symptom severity predict changes in C-reactive protein, or vice versa, in patients with acute coronary syndromes?
In patients with acute coronary syndromes, baseline depressive symptoms predict a smaller decrease in inflammation (CRP) at 1 month, but inflammation does not predict subsequent depressive symptoms.
Answers are grounded in this paper and cite their sources.
Depressive symptoms may slow post-ACS CRP resolution; leaves open bidirectional links and clinical relevance pending prospective trials.
OBJECTIVE: Previous theoretical models predict that elevated inflammation may predict later depressive symptoms, but bidirectional associations are possible. We examined whether depressive symptoms or inflammation predicts change in the other for a 3-month period in a sample of adults with acute coronary syndromes (ACS). METHODS: During hospitalization for their index ACS event (baseline) and then again 1 and 3 months later, 163 post-ACS patients completed the Beck Depression Inventory, a measure of depressive symptom severity with cognitive-affective and somatic-affective subscales. C-reactive protein (CRP) was also assessed at each visit; known correlates of depression and CRP were assessed at baseline. Path analyses were conducted to evaluate prospective associations between depressive symptoms and log-transformed CRP values and whether strength and/or directionality varied by specific depressive symptom dimensions. RESULTS: Baseline total depressive symptom severity predicted a smaller decrease in CRP from baseline to 1 month (unstandardized parameter estimates [B] = 0.04, p < .001) controlling for all covariates, as did baseline cognitive-affective depressive symptom severity (B = 0.10, p = .02). Baseline somatic-affective depressive symptom severity did not predict change in CRP (B = -0.002, p = .94). CRP did not predict 1- or 3-month change in total, cognitive-affective, or somatic-affective depressive symptom severity. The results did not differ for men and women. CONCLUSIONS: Greater cognitive-affective and total depressive symptom severity at the time of a cardiac event predicts a smaller decrease in CRP 1 month later, but there was no evidence in this study that CRP predicts change in depressive symptoms.
No takes yet. Share an insight, caveat, or question.
Shaffer et al. (2011) conducted a cohort in Acute coronary syndromes (n=163). Depressive symptom severity was evaluated on Change in C-reactive protein (CRP) from baseline to 1 month (B = 0.04, p=<0.001). Baseline total depressive symptom severity predicted a smaller decrease in C-reactive protein 1 month after an acute coronary syndrome event.
Synapse has enriched 10 related papers. Consider them for comparative context: